Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22555463 | 0.82 | ALDH1A1 (0.55) | GAAALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL25229209 | 0.79 | HTR2A (0.50) | GAAALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL25678359 | 0.78 | HTR2A (0.47) | ALDH1A1POLBHTR2AHTR2CHTR2B | |
| SCHEMBL20898145 | 0.78 | PBRM1 (0.47) | GAAALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL24746654 | 0.76 | HTR6 (0.49) | ALDH1A1KDM4EKMT2AMEN1MAPT | |
| SCHEMBL25192370 | 0.75 | HTR2A (0.64) | GAAALDH1A1KDM4EKMT2AMEN1 | |
| SCHEMBL31310148 | 0.75 | SLC6A4 (0.44) | GAAALDH1A1KMT2ANPSR1HTR2A | |
| SCHEMBL12558840 | 0.74 | HTR2A (0.57) | ALDH1A1MAPTTDP1L3MBTL1HTR2A | |
| SCHEMBL25118462 | 0.74 | SLC22A6 (0.47) | ALDH1A1KDM4ETDP1HTR2AHTR2C | |
| SCHEMBL5694486 | 0.73 | ALDH1A1 (0.69) | GAAALDH1A1KDM4EKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368665-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2025-12-04 | — | — | US | disclosed |
| US-20250361251-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2025-11-27 | — | — | US | disclosed |
| US-12459965-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2025-11-04 | — | — | US | disclosed |
| US-20250320240-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | COMPASS PATHFINDER LTD (GB) | 2025-10-16 | — | — | US | disclosed |
| WO-2025215243-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | COMPASS PATHFINDER LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |
| US-20250122232-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2025-04-17 | — | — | US | disclosed |
| US-20240199660-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2024-06-20 | — | — | US | disclosed |
| US-11939346-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2024-03-26 | — | — | US | disclosed |
| US-11851451-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2023-12-26 | — | — | US | disclosed |
| US-20230250115-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2023-08-10 | — | — | US | disclosed |
| US-20210155642-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2021-05-27 | — | — | US | disclosed |
| US-20210087212-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2021-03-25 | — | — | US | disclosed |
| US-10954259-B1 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2021-03-23 | — | — | US | disclosed |
| US-10947257-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2021-03-16 | — | — | US | disclosed |
| US-20200331939-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | Compass Pathways Limited (GB) | 2020-10-22 | — | — | US | disclosed |
| EP-3694835-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | Compass Pathways Limited (GB) | 2020-08-19 | — | — | EP | disclosed |
| CN-111491919-A | Preparation of siloxibin, different polymorphic forms, intermediates, formulations and uses thereof | 指南针路径有限公司 | 2020-08-04 | — | — | CN | disclosed |
| US-20200199161-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | Compass Pathways Limited (GB) | 2020-06-25 | — | — | US | disclosed |
| US-20190119310-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HERCULES CAPITAL, INC. | 2019-04-25 | — | — | US | disclosed |
| WO-2019073379-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | Compass Pathways Limited (GB) | 2019-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939346-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-12459965-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20250122232-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-11851451-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-10947257-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20210087212-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20250320240-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | HTR3C, HTR4, UGT8 | GAA 533/4885ALDH1A1 2058/4885KDM4E 1755/4885 |
| US-20210155642-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-10954259-B1 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20250368665-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20200199161-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20200331939-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20190119310-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20240199660-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20230250115-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
| US-20250361251-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | GAA 3218/4885ALDH1A1 3470/4885KDM4E 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.